Please note: This trial has finished recruiting and is not accepting new participants.

Research Centre: Scientia Clinical Research
Location: Level 5 Bright Building, Corner High and Avoca St, Randwick NSW 2031, Australia
Ethics Committee: This study has been reviewed and approved by Bellberry Human Research Ethics Committee

Background

 

More than 123 million people worldwide have psoriasis. Psoriasis is an inflammatory skin disease that produces scaly, reddened lesions (plaques) often combined with skin thickening.

This study presents a new investigational medication to potentially treat people suffering from psoriasis. This study seeks to investigate the potential benefit and effectiveness of this potential medication that  is designed to treat psoriasis by reducing inflammation.

The study seeks adults aged 18 to 75 years old who are suffering from psoriasis, specifically the plaque-type, for at least 6 months. Participants are required to attend 8 study visits at the research site over approximately 5 months. They must also be willing to undergo 2 skin biopsies and will be reimbursed  for their participation in this study. 

Why Participate? 

 

• You may experience improvements to your psoriasis symptoms.
• You may receive potential treatment for your psoriasis.
• You may be able to better manage psoriasis symptoms.
• You will be reimbursed for participating in this study.
• You will be helping to advance medical research.

Your Rights

 

• If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
• Your records relating to this study and any other information received will be kept strictly confidential, except as required by the law.
• Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

 

• Adults aged 18 to 75 years old who are diagnosed with plaque-type psoriasis.
• Must be experiencing plaque-type psoriasis for more than 6 months
• Must be willing to perform 2 skin biopsies. 
• Able to attend 8 study visits at the research site over approximately 5 months